Please login to the form below

Not currently logged in
Email:
Password:

progressive pulmonary fibrosis

This page shows the latest progressive pulmonary fibrosis news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim enrols first patient in pulmonary fibrosis phase 3 trial

Boehringer Ingelheim enrols first patient in pulmonary fibrosis phase 3 trial

Boehringer Ingelheim has enrolled the first patient in its global phase 3 trial evaluating BI 1015550, an investigational phosphodiesterase 4B inhibitor, in patients with idiopathic pulmonary fibrosis (IPF), the company announced. ... New treatments for

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Pharma deals during August 2014 Pharma deals during August 2014

    This brings a much needed boost to its respiratory portfolio, which currently consists of Pulmozyme (cystic fibrosis) and Xolair (severe asthma) and products in clinical development, eg lebrikizumab (severe asthma). ... Pirfenidone is under regulatory

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....